RSS-Feed abonnieren
DOI: 10.1055/s-0031-1299681
Outcomes of Adrenalectomy in Patients with Unilateral Primary Aldosteronism: A Review
Publikationsverlauf
received 26. September 2011
accepted 01. Dezember 2011
Publikationsdatum:
13. Januar 2012 (online)

Abstract
Aldosterone hypersecretion in primary aldosteronism is unilateral (aldosterone producing adenoma and primary unilateral hyperplasia) or bilateral (idiopathic adrenal hyperplasia). Laparoscopic adrenalectomy is nowadays the preferred approach to treat patients with unilateral primary aldosteronism. We review the outcomes of this intervention in recently published series. Laparoscopic adrenalectomy has a morbidity of 5–14%, mortality below 1%, and a mean hospital stay around 3 days. It generally results in the normalization of aldosterone secretion and in a large decrease of blood pressure and antihypertensive medication, but normotension without treatment is only achieved in 42% of all cases. Normotension following adrenalectomy is more likely in young and lean women with recent low grade hypertension than in obese men with long-standing high grade hypertension or a family history of hypertension. However, individual prediction of the blood pressure outcome is not accurate and predictors of hypertension cure should not be used to select patients for surgery. Age, associated health conditions and preferences of the patient are more relevant to this end.
-
References
- 1 Amar L, Plouin PF, Steichen O. Aldosterone-producing adenoma and other surgically correctable forms of primary aldosteronism. Orphanet J Rare Dis 2010; 5: 9
- 2 Omura M, Sasano H, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T. Clinical characteristics of aldosterone-producing microadenoma, macroadenoma, and idiopathic hyperaldosteronism in 93 patients with primary aldosteronism. Hypertens Res 2006; 29: 883-889
- 3 Connell JM, MacKenzie SM, Freel EM, Fraser R, Davies E. A lifetime of aldosterone
excess: long-term consequences of altered regulation of aldosterone production for
cardiovascular function. Endocr Rev 2008; 29: 133-154
MissingFormLabel
- 4 Gagner M, Lacroix A, Bolte E. Laparoscopic adrenalectomy in Cushing’s syndrome and pheochromocytoma. N Engl J Med 1992; 327: 1033
- 5 Chavez-Rodriguez J, Pasieka JL. Adrenal lesions assessed in the era of laparoscopic adrenalectomy: a modern day series. Am J Surg 2005; 189: 581-585 discussion 585–586
- 6 Quinkler M, Stewart PM. Treatment of primary aldosteronism. Best Pract Res Clin Endocrinol Metab 2010; 24: 923-932
- 7 Assalia A, Gagner M. Laparoscopic adrenalectomy. Br J Surg 2004; 91: 1259-1274
- 8 Naya Y, Nagata M, Ichikawa T, Amakasu M, Omura M, Nishikawa T, Yamaguchi K, Ito H. Laparoscopic adrenalectomy: comparison of transperitoneal and retroperitoneal approaches. BJU Int 2002; 90: 199-204
- 9 Berber E, Tellioglu G, Harvey A, Mitchell J, Milas M, Siperstein A. Comparison of laparoscopic transabdominal lateral versus posterior retroperitoneal adrenalectomy. Surgery 2009; 146: 621-625 discussion 625–626
- 10 Brunt LM. Minimal access adrenal surgery. Surg Endosc 2006; 20: 351-361
- 11 Yuge K, Miyajima A, Hasegawa M, Miyazaki Y, Maeda T, Takeda T, Takeda A, Miyashita K, Kurihara I, Shibata H, Kikuchi E, Oya M. Initial experience of transumbilical laparoendoscopic single-site surgery of partial adrenalectomy in patient with aldosterone-producing adenoma. BMC Urol 2010; 10: 19
- 12 Cadiere GB, Himpens J, Germay O, Izizaw R, Degueldre M, Vandromme J, Capelluto E, Bruyns J. Feasibility of robotic laparoscopic surgery: 146 cases. World J Surg 2001; 25: 1467-1477
- 13 Hyams ES, Stifelman MD. The role of robotics for adrenal pathology. Curr Opin Urol 2009; 19: 89-96
- 14 Ramirez-Plaza CP, Gallego Perales JL, Camero NM, Rodriguez-Canete A, Bondia-Navarro JA, Santoyo-Santoyo J. Outpatient laparoscopic adrenalectomy: a new step ahead. Surg Endosc 2011; 25: 2570-2573
- 15 Walz MK, Alesina PF, Wenger FA, Deligiannis A, Szuczik E, Petersenn S, Ommer A, Groeben H, Peitgen K, Janssen OE, Philipp T, Neumann HP, Schmid KW, Mann K. Posterior retroperitoneoscopic adrenalectomy – results of 560 procedures in 520 patients. Surgery 2006; 140: 943-948 discussion 948–950
- 16 Tessier DJ, Iglesias R, Chapman WC, Kercher K, Matthews BD, Gorden DL, Brunt LM. Previously unreported high-grade complications of adrenalectomy. Surg Endosc 2009; 23: 97-102
- 17 Boulkroun S, Samson-Couterie B, Dzib JF, Lefebvre H, Louiset E, Amar L, Plouin PF,
Lalli E, Jeunemaitre X, Benecke A, Meatchi T, Zennaro MC. Adrenal cortex remodeling
and functional zona glomerulosa hyperplasia in primary aldosteronism. Hypertension
2010; 56: 885-892
MissingFormLabel
- 18 Omura M, Sasano H, Fujiwara T, Yamaguchi K, Nishikawa T. Unique cases of unilateral hyperaldosteronemia due to multiple adrenocortical micronodules, which can only be detected by selective adrenal venous sampling. Metabolism 2002; 51: 350-355
- 19 Ishidoya S, Ito A, Sakai K, Satoh M, Chiba Y, Sato F, Arai Y. Laparoscopic partial
versus total adrenalectomy for aldosterone producing adenoma. J Urol 2005; 174: 40-43
MissingFormLabel
- 20 Kaye DR, Storey BB, Pacak K, Pinto PA, Linehan WM, Bratslavsky G. Partial adrenalectomy: underused first line therapy for small adrenal tumors. J Urol 2010; 184: 18-25
- 21 Fu B, Zhang X, Wang GX, Lang B, Ma X, Li HZ, Wang BJ, Shi TP, Ai X, Zhou HX, Zheng
T. Long-term results of a prospective, randomized trial comparing retroperitoneoscopic
partial versus total adrenalectomy for aldosterone producing adenoma. J Urol 2011;
185: 1578-1582
MissingFormLabel
- 22 Minowada S, Fujimura T, Takahashi N, Kishi H, Hasuo K, Minami M. Computed tomography-guided percutaneous acetic acid injection therapy for functioning adrenocortical adenoma. J Clin Endocrinol Metab 2003; 88: 5814-5817
- 23 Hokotate H, Inoue H, Baba Y, Tsuchimochi S, Nakajo M. Aldosteronomas: experience with superselective adrenal arterial embolization in 33 cases. Radiology 2003; 227: 401-406
- 24 Liu SY, Ng EK, Lee PS, Wong SK, Chiu PW, Mui WL, So WY, Chow FC. Radiofrequency ablation for benign aldosterone-producing adenoma: a scarless technique to an old disease. Ann Surg 2010; 252: 1058-1064
- 25 The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V) . Arch Intern Med 1993; 153: 154-183
- 26 Mulatero P, Stowasser M, Loh KC, Fardella CE, Gordon RD, Mosso L, Gomez-Sanchez CE,
Veglio F, Young Jr WF. Increased diagnosis of primary aldosteronism, including surgically
correctable forms, in centers from five continents. J Clin Endocrinol Metab 2004;
89: 1045-1050
MissingFormLabel
- 27 Sawka AM, Young WF, Thompson GB, Grant CS, Farley DR, Leibson C, van Heerden JA. Primary aldosteronism: factors associated with normalization of blood pressure after surgery. Ann Intern Med 2001; 135: 258-261
- 28 Lumachi F, Ermani M, Basso SM, Armanini D, Iacobone M, Favia G. Long-term results of adrenalectomy in patients with aldosterone-producing adenomas: multivariate analysis of factors affecting unresolved hypertension and review of the literature. Am Surg 2005; 71: 864-869
- 29 Satoh F, Abe T, Tanemoto M, Nakamura M, Abe M, Uruno A, Morimoto R, Sato A, Takase K, Ishidoya S, Arai Y, Suzuki T, Sasano H, Ishibashi T, Ito S. Localization of aldosterone-producing adrenocortical adenomas: significance of adrenal venous sampling. Hypertens Res 2007; 30: 1083-1095
- 30 Pang TC, Bambach C, Monaghan JC, Sidhu SB, Bune A, Delbridge LW, Sywak MS. Outcomes of laparoscopic adrenalectomy for hyperaldosteronism. ANZ J Surg 2007; 77: 768-773
- 31 Rossi GP, Bolognesi M, Rizzoni D, Seccia TM, Piva A, Porteri E, Tiberio GA, Giulini SM, Agabiti-Rosei E, Pessina AC. Vascular remodeling and duration of hypertension predict outcome of adrenalectomy in primary aldosteronism patients. Hypertension 2008; 51: 1366-1371
- 32 Letavernier E, Peyrard S, Amar L, Zinzindohoue F, Fiquet B, Plouin PF. Blood pressure
outcome of adrenalectomy in patients with primary hyperaldosteronism with or without
unilateral adenoma. J Hypertens 2008; 26: 1816-1823
MissingFormLabel
- 33 Zarnegar R, Lee J, Brunaud L, Lindsay S, Kebebew E, Clark OH, Duh QY. Good blood pressure control on antihypertensives, not only response to spironolactone, predicts improved outcome after adrenalectomy for aldosteronoma. Surgery 2007; 142: 921-929 discussion 921–929
- 34 Zarnegar R, Young Jr WF, Lee J, Sweet MP, Kebebew E, Farley DR, Thompson GB, Grant CS, Clark OH, Duh QY. The aldosteronoma resolution score: predicting complete resolution of hypertension after adrenalectomy for aldosteronoma. Ann Surg 2008; 247: 511-518
- 35 Walz MK, Gwosdz R, Levin SL, Alesina PF, Suttorp AC, Metz KA, Wenger FA, Petersenn
S, Mann K, Schmid KW. Retroperitoneoscopic adrenalectomy in Conn’s syndrome caused
by adrenal adenomas or nodular hyperplasia. World J Surg 2008; 32: 847-853
MissingFormLabel
- 36 White ML, Gauger PG, Doherty GM, Cho KJ, Thompson NW, Hammer GD, Miller BS. The role of radiologic studies in the evaluation and management of primary hyperaldosteronism. Surgery 2008; 144: 926-933 discussion 933
- 37 Mourad JJ, Girerd X, Milliez P, Lopez-Sublet M, Lejeune S, Safar ME. Urinary aldosterone-to-active-renin ratio: a useful tool for predicting resolution of hypertension after adrenalectomy in patients with aldosterone-producing adenomas. Am J Hypertens 2008; 21: 742-747
- 38 Chiou TT, Chiang PH, Fuh M, Liu RT, Lee WC, Lee WC, Ng HY, Tsai YC, Chuang FR, Huang CC, Lee CT. Factors determining cardiovascular and renal outcomes after adrenalectomy in patients with aldosterone-producing adrenal adenoma. Tohoku J Exp Med 2009; 218: 17-24
- 39 Campagnacci R, Crosta F, De Sanctis A, Baldarelli M, Giacchetti G, Paganini AM, Coletta M, Guerrieri M. Long-term results of laparoscopic adrenalectomy for primary aldosteronism. J Endocrinol Invest 2009; 32: 57-62
- 40 Wu VC, Chueh SC, Chang HW, Lin LY, Liu KL, Lin YH, Ho YL, Lin WC, Wang SM, Huang KH, Hung KY, Kao TW, Lin SL, Yen RF, Chen YM, Hsieh BS, Wu KD. Association of kidney function with residual hypertension after treatment of aldosterone-producing adenoma. Am J Kidney Dis 2009; 54: 665-673
- 41 Murashima M, Trerotola SO, Fraker DL, Han D, Townsend RR, Cohen DL. Adrenal venous sampling for primary aldosteronism and clinical outcomes after unilateral adrenalectomy: a single-center experience. J Clin Hypertens (Greenwich) 2009; 11: 316-323
- 42 Tresallet C, Salepcioglu H, Godiris-Petit G, Hoang C, Girerd X, Menegaux F. Clinical outcome after laparoscopic adrenalectomy for primary hyperaldosteronism: the role of pathology. Surgery 2010; 148: 129-134
- 43 Wang B, Zhang G, Ouyang J, Deng X, Shi T, Ma X, Li H, Ju Z, Wang C, Wu Z, Liu S, Zhang X. Association of DNA polymorphisms within the CYP11B2/CYP11B1 locus and postoperative hypertension risk in the patients with aldosterone-producing adenomas. Urology 2010; 76: e1011-e1017 e1018
- 44 Waldmann J, Maurer L, Holler J, Kann PH, Ramaswamy A, Bartsch DK, Langer P. Outcome of Surgery for Primary Hyperaldosteronism. World J Surg 2011; 35: 2422-2427
- 45 Ishidoya S, Kaiho Y, Ito A, Morimoto R, Satoh F, Ito S, Ishibashi T, Nakamura Y, Sasano H, Arai Y. Single-center outcome of laparoscopic unilateral adrenalectomy for patients with primary aldosteronism: lateralizing disease using results of adrenal venous sampling. Urology 2011; 78: 68-73
- 46 Stowasser M, Gordon RD. Primary aldosteronism – careful investigation is essential and rewarding. Mol Cell Endocrinol 2004; 217: 33-39
- 47 Kline GA, Harvey A, Jones C, Hill MH, So B, Scott-Douglas N, Pasieka JL. Adrenal vein sampling may not be a gold-standard diagnostic test in primary aldosteronism: final diagnosis depends upon which interpretation rule is used. Variable interpretation of adrenal vein sampling. Int Urol Nephrol 2008; 40: 1035-1043
- 48 Lau JH, Sze WC, Reznek RH, Matson M, Sahdev A, Carpenter R, Berney DM, Akker SA, Chew SL, Grossman AB, Monson JP, Drake WM. A prospective Evaluation Of Postural Stimulation Testing, Computed Tomography And Adrenal Vein Sampling In The Differential Diagnosis Of Primary Aldosteronism. Clin Endocrinol (Oxf) 2011; Sep 7 [Epub ahead of print]
- 49 Ghose RP, Hall PM, Bravo EL. Medical management of aldosterone-producing adenomas. Ann Intern Med 1999; 131: 105-108
- 50 Yoshitomi Y, Nishikimi T, Abe H, Yoshiwara F, Suzuki T, Ashizawa A, Nagata S, Kuramochi M, Matsuoka H, Omae T. Comparison of changes in cardiac structure after treatment in secondary hypertension. Hypertension 1996; 27: 319-323
- 51 Rossi GP, Sacchetto A, Visentin P, Canali C, Graniero GR, Palatini P, Pessina AC.
Changes in left ventricular anatomy and function in hypertension and primary aldosteronism.
Hypertension 1996; 27: 1039-1045
MissingFormLabel
- 52 Giacchetti G, Ronconi V, Turchi F, Agostinelli L, Mantero F, Rilli S, Boscaro M.
Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism:
an observational study. J Hypertens 2007; 25: 177-186
MissingFormLabel
- 53 Lin YH, Huang KH, Lee JK, Wang SM, Yen RF, Wu VC, Chung SD, Liu KL, Chueh SC, Lin LY, Ho YL, Chen MF, Wu KD. Factors influencing left ventricular mass regression in patients with primary aldosteronism post adrenalectomy. J Renin Angiotensin Aldosterone Syst 2011; 12: 48-53
- 54 Catena C, Colussi G, Lapenna R, Nadalini E, Chiuch A, Gianfagna P, Sechi LA. Long-term
cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with
primary aldosteronism. Hypertension 2007; 50: 911-918
MissingFormLabel
- 55 Rossi GP, Sacchetto A, Pavan E, Palatini P, Graniero GR, Canali C, Pessina AC. Remodeling
of the left ventricle in primary aldosteronism due to Conn’s adenoma. Circulation
1997; 95: 1471-1478
MissingFormLabel
- 56 Catena C, Colussi G, Nadalini E, Chiuch A, Baroselli S, Lapenna R, Sechi LA. Cardiovascular
outcomes in patients with primary aldosteronism after treatment. Arch Intern Med 2008;
168: 80-85
MissingFormLabel
- 57 Ribstein J, Du Cailar G, Fesler P, Mimran A. Relative glomerular hyperfiltration
in primary aldosteronism. J Am Soc Nephrol 2005; 16: 1320-1325
MissingFormLabel
- 58 Sechi LA, Novello M, Lapenna R, Baroselli S, Nadalini E, Colussi GL, Catena C. Long-term
renal outcomes in patients with primary aldosteronism. JAMA 2006; 295: 2638-2645
MissingFormLabel
- 59 Catena C, Colussi G, Nadalini E, Chiuch A, Baroselli S, Lapenna R, Sechi LA. Relationships
of plasma renin levels with renal function in patients with primary aldosteronism.
Clin J Am Soc Nephrol 2007; 2: 722-731
MissingFormLabel
- 60 Sechi LA, Di Fabio A, Bazzocchi M, Uzzau A, Catena C. Intrarenal hemodynamics in
primary aldosteronism before and after treatment. J Clin Endocrinol Metab 2009; 94:
1191-1197
MissingFormLabel
- 61 Reincke M, Rump LC, Quinkler M, Hahner S, Diederich S, Lorenz R, Seufert J, Schirpenbach
C, Beuschlein F, Bidlingmaier M, Meisinger C, Holle R, Endres S. Risk factors associated
with a low glomerular filtration rate in primary aldosteronism. J Clin Endocrinol
Metab 2009; 94: 869-875
MissingFormLabel
- 62 Pimenta E, Gordon RD, Ahmed AH, Cowley D, Robson D, Kogovsek C, Stowasser M. Unilateral adrenalectomy improves urinary protein excretion but does not abolish its relationship to sodium excretion in patients with aldosterone-producing adenoma. J Hum Hypertens 2011; 25: 592-599
- 63 Wu VC, Kuo CC, Wang SM, Liu KL, Huang KH, Lin YH, Chu TS, Chang HW, Lin CY, Tsai CT, Lin LY, Chueh SC, Kao TW, Chen YM, Chiang WC, Tsai TJ, Ho YL, Lin SL, Wang WJ, Wu KD. Primary aldosteronism: changes in cystatin C-based kidney filtration, proteinuria, and renal duplex indices with treatment. J Hypertens 2011; 29: 1778-1786
- 64 Wu VC, Yang SY, Lin JW, Cheng BW, Kuo CC, Tsai CT, Chu TS, Huang KH, Wang SM, Lin
YH, Chiang CK, Chang HW, Lin CY, Lin LY, Chiu JS, Hu FC, Chueh SC, Ho YL, Liu KL,
Lin SL, Yen RF, Wu KD. Kidney impairment in primary aldosteronism. Clin Chim Acta
2011; 412: 1319-1325
MissingFormLabel
- 65 Matrozova J, Steichen O, Amar L, Zacharieva S, Jeunemaitre X, Plouin PF. Fasting
plasma glucose and serum lipids in patients with primary aldosteronism: a controlled
cross-sectional study. Hypertension 2009; 53: 605-610
MissingFormLabel
- 66 Somloova Z, Widimsky Jr J, Rosa J, Wichterle D, Strauch B, Petrak O, Zelinka T, Vlkova J, Masek M, Dvorakova J, Holaj R. The prevalence of metabolic syndrome and its components in two main types of primary aldosteronism. J Hum Hypertens 2010; 24: 625-630
- 67 Sukor N, Gordon RD, Ku YK, Jones M, Stowasser M. Role of unilateral adrenalectomy
in bilateral primary aldosteronism: a 22-year single center experience. J Clin Endocrinol
Metab 2009; 94: 2437-2445
MissingFormLabel
- 68 Ahmed AH, Gordon RD, Sukor N, Pimenta E, Stowasser M. Quality of Life in Patients
with Bilateral Primary Aldosteronism before and during Treatment with Spironolactone
and/or Amiloride, Including a Comparison with Our Previously Published Results in
Those with Unilateral Disease Treated Surgically. J Clin Endocrinol Metab 2011; 96:
2904-2911
MissingFormLabel
- 69 Sywak M, Pasieka JL. Long-term follow-up and cost benefit of adrenalectomy in patients with primary hyperaldosteronism. Br J Surg 2002; 89: 1587-1593